Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025

Core Insights - Amicus Therapeutics will participate in several investor conferences in March 2025, indicating active engagement with the investment community [1][4] Company Overview - Amicus Therapeutics is a global biotechnology company dedicated to developing high-quality medicines for rare diseases, emphasizing patient focus and innovation [3] - The company aims to advance a pipeline of first- or best-in-class medicines, showcasing its commitment to addressing unmet medical needs in rare diseases [3] Upcoming Events - The company will present at the TD Cowen 45th Annual Health Care Conference in Boston, MA, on March 4, 2025, at 9:50 a.m. ET [4] - Additionally, Amicus Therapeutics will participate in the Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on March 10, 2025, at 10:00 a.m. ET [4]